Antidepressant Use in Pregnancy: What You Need to Know About Safety and Side Effects

Depression during pregnancy is real - and treating it matters

One in seven pregnant people in the U.S. experiences depression. That’s not rare. It’s common. And yet, many women stop taking their antidepressants the moment they find out they’re pregnant, terrified of harming the baby. The fear is understandable. But the data tells a different story. Leaving depression untreated often carries greater risks than staying on medication.

Why untreated depression is more dangerous than antidepressants

When depression goes unmanaged during pregnancy, the effects aren’t just emotional. They’re physical - for both mother and baby. Studies show women with untreated depression are 40% more likely to have a preterm birth. Their babies are 30% more likely to be born underweight. The risk of preeclampsia jumps by 25%. And here’s the hardest truth: depression is the leading cause of pregnancy-related death in the U.S. Between 2017 and 2019, mental health conditions caused nearly a quarter of all maternal deaths, according to CDC data. That’s more than bleeding, infection, or high blood pressure alone.

Women with depression are also less likely to show up for prenatal visits. They’re more likely to smoke, drink, or skip prenatal vitamins. They’re more likely to feel isolated, overwhelmed, and hopeless. These aren’t just symptoms - they’re threats to survival.

Which antidepressants are safest during pregnancy?

Not all antidepressants are created equal. The most commonly prescribed are SSRIs - selective serotonin reuptake inhibitors. Among these, sertraline (Zoloft) has the strongest safety record. It’s the first-line choice for most doctors because it’s been studied in more pregnant women than any other SSRI. Citalopram (Celexa) and escitalopram (Lexapro) are also considered low-risk.

There’s one exception: paroxetine (Paxil). It’s linked to a higher chance of heart defects in babies - 1.5 to 2 times higher than other SSRIs. If you’re taking paroxetine and planning pregnancy, talk to your doctor about switching. You don’t have to stay on it.

Fluoxetine (Prozac) is another option, but it carries a slightly higher risk of a rare lung condition in newborns called persistent pulmonary hypertension (PPHN). The risk is still low - about 5 to 6 cases per 1,000 births compared to 2 to 3 in unexposed babies - but it’s enough for doctors to prefer sertraline first.

Do antidepressants cause birth defects?

Early studies raised alarms. They showed a small increase in birth defects among babies exposed to SSRIs. But those studies didn’t account for one crucial thing: the mothers’ depression itself.

Later, smarter research came along. One 2018 meta-analysis looked at nearly 30 high-quality studies. When researchers compared women taking SSRIs to women with depression who weren’t taking meds, the difference in birth defects vanished. The odds ratio dropped from 1.25 to 1.04 - meaning no real increase in risk. The same pattern held for other issues like low birth weight or developmental delays.

By 2025, the Society for Maternal-Fetal Medicine declared clearly: “The available data consistently show that SSRI use during pregnancy is not associated with congenital anomalies, fetal growth problems, or long-term developmental problems.”

What about neonatal adaptation syndrome?

This is the most common real side effect - and it’s temporary. About 30% of babies exposed to SSRIs in the last trimester may have jitteriness, trouble feeding, or mild breathing issues right after birth. These symptoms usually last less than two weeks and don’t need special treatment. They’re not brain damage. They’re not long-term harm. They’re just the baby’s body adjusting to life outside the womb without the medication.

Doctors watch for these signs in the first 48 hours. Most babies go home on time with no issues. If your baby does have mild symptoms, it doesn’t mean you made the wrong choice. It means your baby is normal.

What happens if you stop your meds?

Stopping antidepressants during pregnancy is risky - and often unnecessary. One study found that 68% of women who quit their meds during pregnancy had a major depression relapse. Only 26% of those who stayed on medication did. That’s a huge gap.

And it’s getting worse. In January 2025, a JAMA study showed that antidepressant refills among pregnant women dropped by 50% compared to the year before pregnancy. Meanwhile, psychotherapy use didn’t go up. So women are stopping meds - but not getting other help.

It’s not safer. It’s more dangerous.

Can you switch or lower your dose?

Yes - and you should do it with help. If you’re on paroxetine, switching to sertraline before or early in pregnancy is smart. If your depression is mild and you’ve been stable for months, your doctor might suggest lowering the dose. But never stop cold turkey. Sudden withdrawal can cause anxiety, dizziness, nausea, and even trigger a depressive episode.

The goal isn’t to avoid all medication. It’s to use the right one, at the lowest effective dose. Most women do fine on 50-100 mg of sertraline daily. Higher doses aren’t always better. And if you’re already stable, there’s usually no reason to change.

What about therapy and other treatments?

Medication isn’t the only tool. Cognitive behavioral therapy (CBT) works just as well as SSRIs for mild to moderate depression during pregnancy. Exercise - even walking 30 minutes a day - has been shown to lift mood. Support groups, mindfulness, and sleep hygiene all help.

But here’s the catch: therapy takes time, money, and access. Not everyone can get it. And for severe depression, therapy alone often isn’t enough. That’s why experts say the best approach combines both - medication when needed, plus therapy when possible.

The FDA controversy and why it confused everyone

In July 2025, an FDA expert panel released a statement that sent panic through the medical community. It suggested SSRIs might be riskier than previously thought. But here’s what they didn’t say: only one of the ten panelists was a specialist in perinatal psychiatry. Most had no clinical experience treating pregnant women.

ACOG immediately pushed back. Their president called the panel “alarmingly unbalanced.” They warned that the report would scare women into stopping life-saving treatment. And they were right. Within weeks, clinics reported a spike in anxiety calls - women afraid to take their meds, even when they were severely depressed.

The truth? The science hasn’t changed. The data still shows SSRIs are safe. The danger isn’t the medication. It’s the silence that follows fear.

What should you do if you’re pregnant and on antidepressants?

• Don’t stop without talking to your doctor. The risk of relapse is too high.
• If you’re on paroxetine, ask about switching to sertraline or citalopram.
• Work with both your OB and a psychiatrist. Team care makes the difference.
• Keep taking your meds unless your provider says otherwise.
• Track your mood. If you feel worse, tell someone - don’t wait.
• Consider therapy, exercise, and support groups alongside medication.

Long-term effects on children? The data says: none

One of the biggest fears is: will my child have autism, ADHD, or learning problems because I took antidepressants?

A 2022 study followed 44,000 children from birth to age five. Half were exposed to SSRIs in utero. Half weren’t. There was no difference in language development, motor skills, behavior, or IQ. Other large studies in Scandinavia and Canada reached the same conclusion.

There’s no evidence that SSRIs harm brain development. But there’s strong evidence that untreated depression does.

You’re not alone. And you’re not doing anything wrong

Taking antidepressants during pregnancy isn’t a failure. It’s a responsible choice. It’s not weakness - it’s strength. You’re choosing to be healthy so you can be there for your child. You’re choosing to break the cycle of silence, shame, and suffering.

The science is clear. The risks of treatment are small. The risks of not treating? They’re life-threatening.